MIRA INFORM REPORT

 

 

Report Date :

23.05.2014

 

IDENTIFICATION DETAILS

 

Name :

ZISKA PHARMACEUTICALS LIMITED

 

 

Registered Office :

Nurul Tower (4th & 5th Floor), 34 Purana Paltan Line, Dhaka-1000

 

 

Country :

Bangladesh

 

 

Date of Incorporation :

10.06.1985

 

 

Com. Reg. No.:

C-14311

 

 

Legal Form :

Private Co 

 

 

Line of Business :

Manufacturer and Exporter of Tablets, Capsules, liquids, Gel, Injections

 

 

No of Employees :

1000

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Bangladesh

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 

 

BANGLADESH - ECONOMIC OVERVIEW

 

Bangladesh's economy has grown roughly 6% per year since 1996 despite political instability, poor infrastructure, corruption, insufficient power supplies, slow implementation of economic reforms, and the 2008-09 global financial crisis and recession. Although more than half of GDP is generated through the service sector, almost half of Bangladeshis are employed in the agriculture sector with rice as the single-most-important product. Garment exports, the backbone of Bangladesh’s industrial sector and 80% of total exports, surpassed $21 billion last year, 18% of GDP. The sector has remained resilient in recent years amidst a series of factory accidents that have killed over 1,000 workers and crippling strikes that shut down virtually all economic activity. Steady garment export growth combined with remittances from overseas Bangladeshis, which totaled almost $15 billion and 13% of GDP IN 2013, are the largest contributors to Bangladesh’s current account surplus and record foreign exchange holdings.

 

Source : CIA

 

 

 

 IDENTIFICATION DETAILS

 

Correct company Name

:

Ziska Pharmaceuticals Limited

Head Office

:

Nurul Tower (4th & 5th Floor), 34 Purana Paltan Line, Dhaka-1000, Bangladesh.

Tel No

:

880-2-9333991

Fax No

:

880-2-8357482, 9359641

E-mail

:

ziska@aitlbd.net

info@ziskapharma.com

aminul@ziskapharma.com

Website

:

www.ziskapharma.com

Date/ Year of Incorporation

:

10/06/1985

Incorporation No.

:

C-14311

Legal Form (General)

:

 Public Listed Co        Public (but not listed)    Private Co   State-owned Co

 Sole Proprietorships   Partnership                     Not Registered

 others (please specify) ________________

Legal form (Specific)

:

LTD   CORP    INC  CO    

 others (please specify) ________________

Issuing Authority

:

Registrar of Joint Stock Companies & Firms      City Corporation

 Municipal Administration                                   Union Council

 Cantonment Board                                              Chief Controller of  Import & Export (CCIE)

 

FINANCIALS- SUMMARY

      Year

Turnover/ Sales

 Assets

     Income

July’ 11~June’ 12

Tk. 610 Million

Tk. 210.50  Million

Tk. 47.35  Million

July’ 12~June’ 13

Tk. 652  Million

Tk. 215.20  Million

Tk. 59.40 Million

Exchange Rate

USD1-Tk. 77.8200

EUR 1- Tk. 100.2711

GBP 1- Tk.118.5354

AUD 1 - Tk.82.8563

JPY 1 - Tk.0.9286

CAD 1 - Tk.80.1887

SEK 1 - Tk.12.2870

SGD 1 - Tk.65.3045

CNH 1 - Tk.12.8399

 

FULLCHECK REPORT DETAILS

 

                                                             Information Parted By

 

 

 

Name

:

Mr. Ifteakharul Alam

Designation

:

Front Desk Officer

Contract No

:

N/A

 

 

                                                               Locations Details

 

Operating Address

:

Nurul Tower (4th & 5th Floor), 34 Purana Paltan Line, Dhaka-1000, Bangladesh.

Tel No

:

880-2-9333991, 9359641

Fax No

:

880-2-8357482

E-mail

:

ziska@aitlbd.net

info@ziskapharma.com

aminul@ziskapharma.com

Website

:

www.ziskapharma.com

 

Location :

: Owned

Ö

 

Rented

 

 

Leased

 

Area

4500

Sq. ft.

 

 

Type of Office :

  :       Commercial Office Bldg.

Ö

 

Semi-commercial office Bldg.

 

     

 

Retail shop

 

 

Industrial Park

 

     

 

Business Center

 

 

Home Office

 

     

 

Residential Bldg.

 

 

 

 

 

 

 

Factory:

 

 

 

 

 

Address

:

Karol Surichala, Shafipur, Khal Kore, Gazipur, Bangladesh.

Tel No

:

N/A

Fax No

:

N/A

 

Location :

   Owned

Ö

 

Rented

 

 

Leased

 

Area

1,71,000

Sq. ft.

 

 

Branches:

 

 

 

 

 

Address

:

Dhaka, Chittagong, Rajshahi, Sylhet, Barisal & Khulna.

Tel No

:

N/A

Fax No

:

N/A

 

 

Employee:

 

 

 

No. of Employees 

 

In Office

:

 

In Factory

:

 

In Branch:

:

 

Total

:

1000

Details:

 

                    

 

 

 

OWNERSHIP/SHAREHOLDERS

 

         Names of Shareholders

No. of Share

Mr. Zakiuddin Ahmed - Shares

8686

Mrs. Sayeda Razzaque

4260

Mr. Md. Aminul Islam Khan

835760

Mrs. Israt Jahan Shirin

99064

Mr. Zahirul Islam Khan

2500

Mrs. Lutfun Nahar

36730

Mr. Monirul Islam Khan

2500

Mrs. Masuma Akter Khanum

500

 

 

DIRECTORS

 

Name

Designation

Mr. Aminul Islam Khan

Managing Director

Mr. Zakiuddin Ahmed

Director

Mrs. Israt Jahan Shirin

Director

Mr. Zahirul Islam Khan

Director

Mrs. Lutfun Nahar

Director

Mr. Monirul Islam Khan

Director

Mrs. Masuma Akter Khanum

Director

Mr. Md. A.H.M. Kamaluddin

Director

Mrs. Nasima Zoha

Director

Mr. Kamrul IslamChisty

Director

Mrs. Naseema Chisty

Director

Mr. Shabnoor Wahid

Director

Mr. Anwarul Islam

Director

 

 

MANAGEMENT

 

Name

:

Mr. Ifteakharul Alam

Job Description

:

Front Desk Officer

Nationality

:

Bangladeshi

Email address

:

N/A

Other details

:

N/A

 

 

BUSINESS OPERATIONS

 

Nature of Activity       :

Manufacturer

Ö

Trader

 

Dealer

 

Distributor

 

 

 

 

Exporter

Ö

Importer

 

Services

 

Others

 

 

Item Dealings In:

 

Products

:

Tablets, Capsules, liquids, Gel, Injections Etc.     

Production Capacity

:

N/A

Last Year Production

:

N/A

 

Trading Terms:

 

Purchasing Terms:

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

Selling Terms      :

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

DETAILED DATA

 

Trade Reference & Related Parties

:

 

Overseas Clients

:

N/A

Local Clients

:

N/A

 

Overseas Suppliers

:

N/A

Local Suppliers

:

N/A

 

Trade Markets

 

:

 

Exports

 

:

N/A

 

Imports

 

:

China, India, Pakistan, Thailand, Germany

 

 

 

Brand Name

:

Nil

Certified

:

Nil

Auditors

:

N/A

Operation Status

:

Active

Member

:

Dhaka Chamber of Commerce & Industry

 

 

CAPITAL STRUCTURE

 

Authorized Capital

:

Tk. 10 Crore

Paid-up Capital

:

Tk. 9,90,00,000

    No. of Shares

:

990000

Share Value

:

Tk.100.00 Each

 

Main Assets

:

Tk. 210.50 Million

 

 

 

 

FINANCIAL STATEMENT- DETAILED

 

The subject company don’t submit update financial figure to local registry office.

 

 

ASSOCIARES/SUBSIDIARIES/ RELATED PARTIES

 

Sister Concerns

:

Nil

Subsidiary

:

N/A

Name of  The Group

:

Nil

 

BANKING

 

Bank Name  

:

AB Bank Ltd.

Bank Address

:

Kakrail Branch.

81, VIP Road, Dhaka 1000

Tel: 9339036, 8315462, 9351177

Fax: 8311324

E-mail: krlbmg@abbank.com.bd

Date of opening: 03.04.89

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks           

 

:     

No Record Found         

Debt

 

:

No Record Found

Litigation  

                   

:

Clear         

Performance Defaults

 

:

No Record Found         

Adverse Local Media Coverage/ Adverse Filling History

:

No Record Found

 

 

SITE VISIT COMMENTARY

 

Our Representative Visited the subject company Head office which is situated at Nurul Tower (4th & 5th Floor), 34 Purana Paltan Line, Dhaka-1000, Bangladesh. The subject company Front Desk Officer Mr. Ifteakharul Alam given us all information. Is situated at commercial area which is a well decorated modern office.

 

GENERAL COMMENTS

 

Based on the financial statements, SC’s financial performance appears to be above average. SC has been in its line of business for about 28 years. Taking into account its long-standing history, reputation in the market, as well as its financial condition, we recommend that Credit can proceed promptly Fairly large amount.

 

 

 

Adopted Abbreviations:

NA- Not Available

 TK- Bangladeshi Taka

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs. 58.57

UK Pound

1

Rs. 98.87

Euro

1

Rs. 80.05

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.